| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 42.5672 | 15 |
| GSM780708 | Untreated after 4 days (C2_1) | 41.7024 | 12 |
| GSM780709 | Untreated after 4 days (C3_1) | 40.4723 | 8 |
| GSM780719 | Untreated after 4 days (C1_2) | 44.5969 | 25 |
| GSM780720 | Untreated after 4 days (C2_2) | 42.2006 | 14 |
| GSM780721 | Untreated after 4 days (C3_2) | 45.4752 | 29 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 44.2352 | 23 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 45.4227 | 29 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 42.9462 | 17 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 47.2781 | 38 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 40.9542 | 9 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 42.9159 | 17 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 43.3615 | 19 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 44.4142 | 24 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 44.835 | 26 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 39.0895 | 4 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 45.0794 | 27 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 43.4217 | 19 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 40.0786 | 7 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 41.0724 | 10 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 42.6629 | 16 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 39.2929 | 5 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 42.5506 | 15 |